My interest is in better defining exercise as a treatment of disease. Exercise is an underutilized medicine, in part because so little data exists to assist practitioners in its appropriate prescription for specific patient groups. My current research charge is to evaluate exercise in pulmonary vasculature disease, both in patients and in rodent models. By defining acute and chronic exercise responses and their underlying mechanisms, we hope to determine which exercise approaches best maximize benefit and minimize potential detriment for this population.
